Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
Ru1EqD8D2fGzULjd